Decreased platelet production |
Autoimmune disorders |
• Acute or chronic leukemia |
• Systemic lupus erythematosus
|
• Myelodysplasia |
• Evans syndrome
|
• Aplastic anemia |
• Antiphospholipid antibodies
|
• Congenital or acquired amegakaryocytic thrombocytopenia |
Drug induced thrombocytopenia |
• Toxic exposure (radiation, chemotherapy, alcohol) |
• Antibiotics (Bactrim, Vancomycin, etc)
|
• Nutritional deficiency (B12, folate) |
• Quinine
|
• Myelofibrosis |
• Valproic Acid
|
• Myelopthistic processes |
• Heparin
|
• Viral infection of hematopoietic precursors |
• Others (oxaliplatin, alemtuzumab, purine analogues)
|
Enhanced platelet destruction |
Infection |
• Splenic sequestration |
• H pylori
|
• Disseminated intravascular coagulation |
• HIV
|
• Thrombotic thrombocytopenic purpura (no direct immune response to platelets) |
• HCV
|
• Cardiopulmonary bypass |
Lymphoproliferative disorders |
• Infection/sepsis |
Immunodeficiency (ALPS, CVID) |
Inherited thrombocytopenia |
Post transfusion purpura |
|
Vaccinations |